Abstract
KIR2DL5B Genotype Independently Predicts Poor Outcomes in CML-CP Patients Switched to Nilotinib after Suboptimal Responses to Imatinib and May Refine Prognosis in Patients with EMR Failure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have